Apoptosis in the skeletal muscle of patients with heart failure: Investigation of clinical and biochemical changes

Heart

Volumn 84, Issue 4, 2000, Pages 431-437

  Vescovo, G ^a   Volterrani, M ^b   Zennaro, R ^a   Sandri, M ^c   Ceconi, C ^b   Lorusso, R ^d   Ferrari, R ^b   Ambrosio, G B ^a   Dalla Libera, L ^c  

^a Venice City Hospital   (Italy)

^b IRCCS   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Apoptosis; Chronic heart failure; Exercise capacity; Myosin heavy chains

Indexed keywords

CASPASE 3; MYOSIN HEAVY CHAIN; PROTEIN BCL 2; UBIQUITIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; EXERCISE; HEART FAILURE; HUMAN; ISCHEMIC HEART DISEASE; MALE; MUSCLE ATROPHY; MUSCLE BIOPSY; MYOPATHY; NICK END LABELING; OXYGEN CONSUMPTION; PRIORITY JOURNAL; VASTUS LATERALIS MUSCLE;

EID: 0033798847     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.84.4.431     Document Type: Article

References (40)

1. Minotti JR, Pillay P, Chang L, et al. Neurophysiological assessment of skeletal muscle fatigue in patients with congestive heart failure. Circulation 1992;86:903-8.
2. Harridge SPR, Magnusson G, Gordon A. Skeletal muscle contractile characteristics and fatigue resistance in patients with chronic heart failure. Eur Heart J 1996;17:896-901.
3. Wiener DH, Fink LI, Jones RA, et al. Abnormal skeletal muscle bioenergetics during exercise in patients with heart failure: role of reduced muscle blood flow. Circulation 1986;73:1127-36.
4. 31P nuclear magnetic resonance spectroscopy study of leg muscle. Clin Sci 1990; 79:583-9.
5. Mancini DM, Ferraro N, Tuchler M, et al. Detection of abnormal calf muscle metabolism in patients with heart failure using phosphorus-31 nuclear magnetic resonance. Am J Cardiol 1988;62:1234-40.
6. Massie BM, Conway M, Rajagopalan B. Skeletal muscle metabolism during exercise under ischemic conditions in congestive heart failure: evidence for abnormalities unrelated to blood flow. Circulation 1988;78:320-6.
7. Coats AJS, Clark AL, Piepoli M, et al. Symptoms and quality of life in heart failure. The muscle hypothesis. Br Heart J 1994;72:36-9.
8. Wilson JR, Fink LI, Maris J. Evaluation of energy metabolism in skeletal muscle of patients with heart failure with gated phosphorus-31 nuclear magnetic resonance. Circulation 1986;71:57-62.
9. Lipkin DP, Jones DA, Round JM, et al. Abnormalities of skeletal muscle in patients with chronic heart failure. Int J Cardiol 1988;18:187-95.
10. Sullivan MJ, Green HJ, Cobb FR. Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation 1990;81:518-27.
11. Vescovo G, Serafini F, Facchin L, et al. Specific changes in skeletal muscle myosin heavy chain composition in cardiac failure. Differences with disuse atrophy as assessed on microbiopsies by a new electrophoretic micromethod. Heart 1996;76:337-43.
12. Vescovo G, Serafini F, Dalla Libera, et al. Skeletal muscle myosin heavy chain composition in CHF. Correlation between the magnitude of the isoenzymatic shift, exercise capacity and gas exchange measurements. Am Heart J 1998;135:130-7.
13. Vescovo G, Dalla Libera L, Serafini F, et al. Improved exercise tolerance after losartan and enalapril in heart failure: correlation with changes in skeletal muscle myosin heavy chain composition. Circulation 1998;98:1742-9.
14. Vescovo G, Zennaro R, Sandri M, et al. Apoptosis of skeletal muscle myofibers and interstitial cells in experimental heart failure. J Mol Cell Cardiol 1998;30:2449-59.
15. Simonini A, Long CS, Dudley GA, et al. Heart failure in rats causes changes in skeletal muscle morphology and gene expression that are not explained by reduced activity. Circ Res 1996;79:128-36.
16. Vescovo G, Ceconi C, Bernocchi P, et al. Skeletal muscle myosin heavy chain expression in rats with monocrotaline-induced cardiac hypertrophy and failure. Relation to blood flow and degree of muscle atrophy. Cardiovasc Res 1998, 39:233-41.
17. Volterrani M, Clark Al, Ludman PF, et al. Predictors of exercise capacity in chronic heart failure. Eur Heart J 1994,15:801-9.
18. Anker SD, Swan JW, Volterrani M, et al. The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non cachectic patients with chronic heart failure. Eur Heart J 1997;18:259-69.
19. Carraro U, Catani C. A sensitive SDS-page method separating myosin heavy chains isoforms of rat skeletal muscle reveals the heterogeneous nature of the embryonic myosin. Biockem Biophys Res Commun 1983;116:793-802.
20. Angelini A, Vescovo G, Calliari I, et al. Correlation between endomyocardial biopsies and ventricle full thickness samples in dilated cardiomyopathy: a study of myocytes and fibrosis. Cardiovasc Pathol 1993;3:167-71.
21. Sandri M, Carraro U, Podhorska-Okolov M, et al. Apoptosis, DNA damage and ubiquitin expression in normal and mdx muscle fibers after exercise. FEBS Lett 1995;373:291-5.
22. Allen DL, Linderman JK, Roy RR, et al. Apoptosis: a mechanism contributing to remodeling of skeletal muscle in response to hindlimb unweighting. Am J Physiol (Cell Physiol) 1997;273:C579-87.
23. Lowry OH. Protein measure with the Folin phenol reagent. J Biol Chem 1951;195:265-75.
24. Weber KT, Wilson JR, Janicki J, et al. Exercise testing in the evaluation of the patient with chronic cardiac failure. Am Rev Respir Dis 1984;29:60-2.
25. Franciosa A, Park M, Levine T. Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure. Am J Cardiol 1981;47:33-9
26. Fink L, Wilson R, Ferraro N. Exercise ventilation and pulmonary wedge pressure in chronic stable congestive heart failure. Am J Cardiol 1986;57:249-53.
27. Adams V, Jiang H, Yu J, et al. Apoptosis in skeletal myocytes of patients with chronic heart failure is associated with exercise intolerance. J Am Coll Cardiol 1999;33:959-65.
28. Narula J, Haider N, Virmani R, et al. Apoptosis in myocytes in end-stage heart failure. N Engl J Med 1996;335:1182-9.
29. Olivetti G, Abbi R, Quaini F, et al. Apoptosis in the failing human heart. N Engl J Med 1997;336:1131-11.
30. Sandri M, Podhorska-Okolow M, Geromel V, et al. Exercise induces myonuclear ubiquitination and apoptosis in dystrophin-deficient muscle of mice. J Neuropathol Exp Neurol 1997;56:45-57.
31. Steller H. Mechanisms and genes of cellular suicide. Science 1995;267:1445-9.
32. Llovera M, Garcia Martinez C, Agell N, et al. TNF can directly induce the expression of ubiquitin-dependent proteolytic system in rat soleus muscles. Biochem Biophys Res Commun 1997;230:238-41.
33. Tews DS, Goebel HH, Schneider I, et al. DNA-fragmentation and expression of apoptosis related proteins in experimentally denervated and reinnervated facial muscle. Neuropathol Appl Neurobiol 1997;23:141-9.
34. Dalla Libera L, Zennaro R, Sandri M et al. Apoptosis and atrophy in rat slow skeletal muscles in chronic heart failure. Am J Physiol (Cell Physiol) 1999;277:C982-6.
35. Mancini DM, Walter G, Reichek N, et al. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation 1992;85: 1364-73.
36. Harrington D, Anker SD, Chua TP, et al. Skeletal muscle function and its ralation to exercise tolerance in chronic heart failure. Am J Coll Cardiol 1997;30:1758-64.
37. Shepard R, Bouhlel E, Vandewalle H. Muscle mass as a factor limiting physical work. J Appl Physiol 1988;64: 1472-9.
38. 2 max. J Appl Physiol 1988;65:1147-51.
39. Anker SD, Coats AJS. Cachexia in heart failure is bad for you. Eur Heart J 1998;19:191-3.
40. Ruegg JC. In: Calcium in muscle contraction, 2nd ed. Berlin: Springer Verlag, 1992:125.